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MicroarraySchizophrenia (SZ) is a severe chronic psychiatric disorder with wide prevalence and high morbidity. We know
little about SZ's etiology and pathophysiology at present. The study of gene expression proﬁle is useful for us to
identify potential biomarkers at molecular level and explain possible pathogenesis of SZ. Therefore we recently
compared gene expression proﬁles in PMBCs from EOS cases and healthy controls using microarrays. Here we
will describe in detail the contents and quality control of the microarray experiment. The raw microarray data
are accessible through GEO series accession number GSE54913.
© 2015 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).od mononuclear cell
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The disease onset before age 18 is generally regarded as early-onset
(EOS) when the patients confer more familial vulnerability and poor
outcomes [1]. The neurodevelopmental hypothesis posits that the
onset of SZ is associated with early development of the nervous systemNanjingMedical University 156
l.: ++86 13358118908.
en access article under the CC BY-NC[2]. We paid attention to this period and speculate that the altered gene
expression in these patientsmay be associatedwith the disease process.
Peripheral blood mononuclear cells (PBMCs) have represented an
accessible tissue source for gene expression, as it is easily collected
from patients. There already have many gene expression proﬁling
studies using PBMCs, a consistent conclusion about the expression alter-
ation of schizophrenia is lacked [3,4].
2. Experimental design, materials and methods
We recently collected blood samples from 18 EOS cases and 12
controls. Then we generated whole-genome gene expression proﬁles on
PBMCs from these samples by using microarray. 17,200 valid probes de-
tected in our experiment were used to identify altered gene expressions.
2.1. Study population
A total of 18 ﬁrst-onset SZ patients (8 males and 10 females, aged
14.78 ± 1.70 years) were included in our study. They were untreated
and drug-naïve patients diagnosed by at least two experienced psychi-
atrists independently according to the Diagnosis and Statistical Manual
of Mental Disorders Fourth Edition (DSM-IV) criteria for SZ. 12 healthy
controls (6males and 6 females, aged 14.75± 2.14 years) were recruit-
ed into the study. Teenagers with a history of other mental health or
neurological diseases were enrolled into our study. All participants-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Quality assessment of mRNA data after ﬁltering. The box-plot shows the distribution of normalized signal intensity by array; the distributions of log2-ratios among all samples are
nearly the same after normalization.
170 L. Sun et al. / Genomics Data 5 (2015) 169–170were unrelatedHanChinese recruited from thenorth of China. Andboth
the participants and their parents signed the informed consent before
participation. The studywas approved byMedical Research Ethics Com-
mittee of Shanxi Medical University.
2.2. Microarray and quality control
Peripheral blood was collected. NanoDrop ND-1000 was used to
quantify total RNA after RNA extraction, and RNA integrity was assessed
by standard denaturing agarose gel electrophoresis. Agilent Array plat-
form was employed to perform the microarray analysis. Following
RNA ampliﬁcation, hybridization and image scanning, signal intensities
were normalized in the quantile method using GeneSpring GX v11.5.1
(Agilent Technologies), and low intensity mRNAs were ﬁltered
(mRNAs that at least 20 out of 30 samples have ﬂags in Present or
Marginal were chosen for further analysis). R [5] was used to perform
the data processing and analyses ofmRNA data. The sample preparation
and microarray hybridization were performed based upon the
manufacturer's standard protocols with minor modiﬁcations.
Log2-rationwas used by quantile normalization. The distributions of
the intensities after normalized among all sampleswere shown in Fig. 1,
Identiﬁcation of differentially expressed genes between SZ cases and
controls was made using R package geneﬁlter [6].We identiﬁed 84Table 1
List of differentially expressed genes.
Up-regulated genes
(82)
C11orf49
SLC18A1
NAT1
MYBPC1
KIF23
GTF2H1
ALDH4A1
IL28RA
ERVFRDE1
ALDH3A1
ODF4
TSPAN16
CCNE1
TGFA
SATB2
SLC45A1
IL1RL2
BBS5
CTLA4
EPPIN
OSGIN1
NKAIN4
EYA2
OPRL1
C21orf56
SLC5A4
GJB5
CCDC134
MYL3
SCAP
PRICKLE2
ENTPD3
RNF186
EIF4G1
UGT2B4
RASSF6
FGA
PAICS
SH3RF2
UBD
ECM1
HOXD11
LCE2D
UBAP2L
RFPL4B
CCL26
DARC
POU6F2
PNMA2
CNGB3
DEFB135
FAM110B
MAL2
SARDH
NUP188
C9orf171
TMEM27
XAGE3
CUL4B
PNCK
SMIM9
ERAS
GAGE10
ATP2B3
TKTL1
USP9Y
LDB1
ACP2
P4HA3
C11orf1
FAM19A2
C12orf68
HCFC2
RPL10L
PRKAB2
CA12
C15orf2
ZP2
SALL1
C16orf46
SLC5A2
GPT2
Down-regulated genes
(2)
IQCF6 POM121L12
(p b 0.05 with a fold change N2).differentially expressed genes through fold change and P value ﬁltering
(FC ≥ 2 and Padjusted b 0.05) listed in Table 1.
3. Discussion
All the participants in our study were teenagers with similar age
(b18 years), and their brains were still developing. The SZ cases were
neither under medication nor had a history of pharmacotherapy. We
mainly described a dataset about gene expression proﬁles of the 30
samples measured by Arraystar.
Among the 84 DE genes listed above, SLC18A1 has been reported to
be associated with SZ [7,8]. In addition, CTLA4 was also identiﬁed
showing a high expression level in SZ [9] which is consistent with the
results from our study. Through our description above, we believe that
this dataset will be useful for the exploration of SZ's pathogenesis in
the future.
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